<DOC>
	<DOCNO>NCT02028689</DOCNO>
	<brief_summary>This study assess potential effect lesinurad pharmacokinetics ( PK ) metformin furosemide healthy , adult male subject .</brief_summary>
	<brief_title>Metformin Furosemide Drug-Drug Interaction Study</brief_title>
	<detailed_description>Leinurad weak vitro inhibitor hepatic transporter OCT1 renal transporter OAT1 OAT3 ( OAT1/3 ) . To assess clinical relevance vitro finding , clinical study evaluate effect lesinurad PK metformin ( OCT1 substrate ) furosemide ( OAT1/3 substrate ) .</detailed_description>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Lesinurad</mesh_term>
	<criteria>Subject body weight ≥ 50 kg ( 110 lb ) body mass index ≥ 18 ≤ 30 kg/m2 . Subject free clinically significant disease medical condition , per Investigator 's judgment . Subject history suspicion kidney stone , prostatic hyperplasia , urinary stricture . Subject undergone major surgery within 3 month prior Screening . Subject donate blood experienced significant blood loss ( &gt; 450 mL ) within 12 week prior Screening give plasma donation within 4 week prior Screening . Subject inadequate venous access unsuitable vein repeat venipuncture .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>